Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.

Feng-Pai TsaiTung-Hung SuShang-Chin HuangTai-Chung TsengShih-Jer HsuSih-Han LiaoChun-Ming HongChen-Hua LiuHung-Chih YangChun-Jen LiuPei-Jer Chen Jia-Horng Kao

Published in: Cancer (2024)

The present research demonstrated that patients with both liver cancer and steatotic liver disease who received curative radiofrequency ablation for liver cancer survived longer compared to those without steatotic liver disease. Maintaining good liver function is an important prognostic factor for survival.

Keyphrases

radiofrequency ablation
prognostic factors
rectal cancer
locally advanced
metabolic syndrome
skeletal muscle
insulin resistance